Visual monitoring of cisplatin-regulated caspase-3 activity in living cells based on reduced graphene oxide-loaded fluorescent probe

Qing Liu,Hongyan Zhou,Wei Zhang,Chuan Zhao,Xueqing Tao,Chunyi Tong,Bin Liu
DOI: https://doi.org/10.1039/d4an01059k
2024-08-21
The Analyst
Abstract:Cisplatin (DDP) is a potent chemotherapeutic drug, which can regulate tumor cells apoptosis by up-regulating caspase-3 activity. Thus, monitoring caspase-3 activity in breast cancer cells can directly illustrate the efficiency of DDP treatment. In this study, by using reduced graphene oxide (rGO) as quencher of fluorescence labeled peptide, we constructed an "off to on" method to monitor the effect of DDP on caspase-3 in breast cancer cells. In this method, the rGO quenched fluorescence with an ultra-high level of efficiency. Caspase-3 hydrolyzed the polypeptide probe, generating two segments of different length. The release of short segment marked with fluorophores led to the recovery of the fluorescence signal (Ex/Em = 450/521 nm). Under the optimal conditions, the linear range of caspase-3 was 0.4-7 U/mL, and the limit of detection was 0.33 U/mL. Upregulating effect of DDP on intracellular caspase-3 activity was visualized with the "off to on" method. And flow cytometry assay showed that caspase-3 activity increased along with the apoptosis rate of tumor cells. The above results showed the practical application of the method for evaluating the efficacy of drugs against cancer cell.
chemistry, analytical
What problem does this paper attempt to address?